B-regulatory cells in autoimmunity and immune mediated inflammation

FEBS Letters

Volumn 587, Issue 13, 2013, Pages 2074-2078

  Vadasz, Zahava ^a   Haj, Tharwat ^a   Kessel, Aharon ^a   Toubi, Elias ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

B regulatory cell Autoimmunity Regulatory marker

Indexed keywords

CD40 LIGAND; CD86 ANTIGEN; CELL MARKER; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; SEMAPHORIN 3A; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNITY; B LYMPHOCYTE; DISEASE CONTROL; HUMAN; IMMUNE MEDIATED INFLAMMATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TH1 CELL;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; B-LYMPHOCYTES, REGULATORY; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INFLAMMATION;

EID: 84878916130     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.05.023     Document Type: Review

References (19)

1. F.E. Lund, and T.D. Randall Effector and regulatory B cells: modulators of CD4(+) T cell immunity Nat. Rev. Immunol. 10 4 2010 236 247
2. S. Wolf, B. Dittel, F. Hardardottir, and C. Janeway Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice J. Exp. Med. 184 1996 2271 2278
3. S. Fillatreau, C. Sweenie, M. McGeachy, D. Gray, and S. Anderton B cells regulate autoimmunity by provision of IL-10 Nat. Immunol. 3 2002 944 950
4. V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. Calderón Gómez, C.H. Sweenie, Y. Hao, A.A. Freitas, U. Steinhoff, S.M. Anderton, and S. Fillatreau TLR-activated B cells suppress T cell-mediated autoimmunity J. Immunol. 180 7 2008 4763 4773
5. M.E. Duddy, A. Alter, and A. Bar-Or Distinct profiles of human B cell effector cytokines: a role in immune regulation? J. Immunol. 172 6 2004 3422 3427
6. M. Brisslert, M. Bokarewa, P. Larsson, K. Wing, L.V. Collins, and A. Tarkowski Phenotypic and functional characterization of human CD25+ B cells Immunology 117 4 2006 548 557
7. S. Amu, A. Tarkowski, T. Dorner, M. Bokarewa, and M. Brisslert The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool Scand. J. Immunol. 66 2007 77 86
8. P. Eriksson, C. Sandell, K. Backteman, and J. Ernerudh B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25+ expressing B cells J. Rheumatol. 37 2010 2086 2095
9. P.A. Blair, L.Y. Norena, F. Flores-Borja, D.J. Rawlings, D.A. Isenberg, M.R. Ehrenstein, and C. Mauri CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus Immunity 32 2010 129 140
10. A. Singh, W.F. Carson 4th, E.R. Secor Jr., L.A. Guernsey, R.A. Flavell, R.B. Clark, R.S. Thrall, and C.M. Schramm Regulatory role of B cells in a murine model of allergic airway disease J. Immunol. 180 11 2008 7318 7326
11. A. Kessel, T. Haj, R. Peri, A. Snir, D. Melamed, E. Sabo, and E. Toubi Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells Autoimmun. Rev. 11 9 2012 670 677
12. H. Sawaki, F. Nakamura, M. Aihara, Y. Nagashima, J. Komori-Yamaguchi, N. Yamashita, M. Nakazawa, Y. Goshima, and Z. Ikezawa Intranasal administration of semaphorin-3A alleviates sneezing and nasal rubbing in a murine model of allergic rhinitis J. Pharmacol. Sci. 117 1 2011 34 44
13. K. Kou, F. Nakamura, M. Aihara, H. Chen, K. Seto, J. Komoro-Yamaguchi, T. Kambara, Y. Nagashima, Y. Goshima, and Z. Ikezawa Decreased expression of semaphorin3A a neurite-collapsing factor, is associated with itch in psoriatic skin Acta Derm. Venereol. 92 2012 521 528
14. Z. Vadasz, T. Haj, K. Halasz, I. Rosner, G. Slobodin, D. Attias, A. Kessel, O. Kessler, G. Neufeld, and E. Toubi Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus Arthritis Res. Ther. 14 3 2012 R146
15. A. Snir, A. Kessel, T. Haj, I. Rosner, G. Slobodin, and E. Toubi Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy Clin. Exp. Rheumatol. 29 4 2011 697 700
16. M. Yang, L. Sun, S. Wang, K.-H. Ko, H. Xu, B.-J. Zheng, X. Cao, and L. Lu Cutting edge: novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells J. Immunol. 184 2010 3321 3325
17. E. Toubi, A. Kessel, G. Slobodin, N. Boulman, E. Palotzky, D. Zisman, M. Rozenbaum, and I. Rosner Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis Ann. Rheum. Dis. 66 2007 818 820
18. E. Toubi, S. Nussbaum, E. Staun-Ram, A. Snir, D. Melamed, L. Hayardeny, and A. Miller Laquinimod modulates B cells and their regulatory effects on T cells in multiple sclerosis J. Neuroimmunol. 251 1-2 2012 45 54
19. A. Catalano The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis J. Immunol. 185 10 2010 6373 6383